Pathfinder Cell Therapy, Inc.
PFND
$0.00
$0.000.00%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -1.08M | -1.08M | -1.19M | -1.39M | -1.56M |
| Total Depreciation and Amortization | 3.00K | 3.00K | 3.00K | 3.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 0.00 | 1.00K | 2.00K | 2.00K |
| Change in Net Operating Assets | 498.00K | 443.00K | 328.00K | 426.00K | 383.00K |
| Cash from Operations | -579.00K | -629.00K | -853.00K | -963.00K | -1.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 609.00K | 652.00K | 860.00K | 1.01M | 1.22M |
| Total Debt Repaid | -49.00K | -44.00K | -52.00K | -60.00K | -74.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 560.00K | 608.00K | 808.00K | 945.00K | 1.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.00K | -21.00K | -45.00K | -18.00K | -28.00K |